Fortis Healthcare Limited
NSE: FORTIS
Employs 14,649 permanent employees and workers, 19.7% on the year before, as filed for the year to 31 Mar 2026 on a group basis. Revenue in the quarter to 31 Dec 2024 was ₹367 cr.
Headcount
Annual, from the BRSR filed with NSE (as of 31 March each year)
| As of | Scope | Permanent | Change (%) | Contract / other | Change (%) |
|---|---|---|---|---|---|
| 31 Mar 2023 | Group | 13,010 | — | 11,260 | — |
| 31 Mar 2024 | Group | 12,088 | −922(7.1%) | 11,255 | −5(0.0%) |
| 31 Mar 2025 | Group | 12,237 | 149(1.2%) | 14,324 | 3,069(27.3%) |
| 31 Mar 2026 | Group | 14,649 | 2,412(19.7%) | 14,967 | 643(4.5%) |
Permanent = permanent employees + permanent workers, as defined in SEBI's BRSR. "Standalone" figures cover the listed company alone and exclude its subsidiaries.
Financials (₹ cr)
| Period | Revenue (₹ cr) | Change (%) | Employee cost (₹ cr) | Change (%) | Net profit (₹ cr) | Change (%) | Flags |
|---|---|---|---|---|---|---|---|
| Quarter ended 31 Dec 2024 | 367 | 10(2.7%) | 52 | 0(0.3%) | 40 | −0(0.2%) | |
| Quarter ended 30 Sept 2024 | 357 | 24(7.1%) | 51 | 2(4.5%) | 40 | 13(47.7%) | |
| Quarter ended 30 Jun 2024 | 333 | 26(8.4%) | 49 | 3(6.9%) | 27 | −42(60.7%) | |
| Quarter ended 31 Mar 2024 | 307 | 17(5.8%) | 46 | 0(0.8%) | 68 | 45(197.9%) | |
| Quarter ended 31 Dec 2023 | 291 | −3(1.1%) | 46 | −1(1.2%) | 23 | −72(75.9%) | |
| Quarter ended 30 Sept 2023 | 294 | 5(1.8%) | 46 | −4(7.8%) | 95 | 82(639.9%) | |
| Quarter ended 30 Jun 2023 | 289 | 12(4.2%) | 50 | 7(15.6%) | 13 | 11(522.2%) | |
| Quarter ended 31 Mar 2023 | 277 | 15(5.8%) | 43 | −2(3.9%) | 2 | −17(89.3%) | |
| Quarter ended 31 Dec 2022 | 262 | 52(24.7%) | 45 | 8(21.6%) | 19 | 44(180.0%) | |
| Quarter ended 31 Mar 2022 | 210 | −18(7.8%) | 37 | −2(4.3%) | -24 | −33(383.5%) | ⚠ |
| Quarter ended 31 Dec 2021 | 228 | 7(3.2%) | 39 | 1(3.9%) | 9 | 4(105.0%) | ⚠ |
| Quarter ended 30 Sept 2021 | 221 | 17(8.5%) | 37 | −4(8.8%) | 4 | 6(341.0%) | ⚠ |
| Quarter ended 30 Jun 2021 | 204 | 9(4.5%) | 41 | 1(2.7%) | -2 | 39(95.8%) | ⚠ |
| Quarter ended 31 Mar 2021 | 195 | 10(5.7%) | 40 | 0(1.1%) | -41 | −62(293.4%) | ⚠ |
| Quarter ended 31 Dec 2020 | 184 | 31(20.4%) | 39 | 6(17.0%) | 21 | 17(412.0%) | ⚠ |
| Quarter ended 30 Sept 2020 | 153 | 53(52.3%) | 34 | −1(2.5%) | 4 | −16(79.1%) | ⚠ |
| Quarter ended 30 Jun 2020 | 101 | −67(40.1%) | 35 | −5(12.1%) | 20 | 12(145.1%) | ⚠ |
| Quarter ended 31 Mar 2020 | 168 | −6(3.5%) | 39 | −1(1.3%) | 8 | −38(82.5%) | ⚠ |
| Quarter ended 31 Dec 2019 | 174 | −8(4.2%) | 40 | 5(12.9%) | 46 | 60(449.7%) | ⚠ |
| Quarter ended 30 Sept 2019 | 181 | 3(1.5%) | 35 | −5(13.5%) | -13 | −485(102.8%) | ⚠ |
| Quarter ended 30 Jun 2019 | 179 | 11(6.5%) | 41 | 7(21.5%) | 472 | 280(145.2%) | ⚠ |
| Quarter ended 31 Mar 2019 | 168 | −2(1.1%) | 34 | −4(10.5%) | 193 | 242(492.0%) | ⚠ |
| Quarter ended 31 Dec 2018 | 170 | 7(4.4%) | 38 | −1(2.3%) | -49 | −43(680.8%) | ⚠ |
| Quarter ended 30 Sept 2018 | 163 | 6(4.0%) | 38 | −2(3.8%) | -6 | 8(55.4%) | ⚠ |
| Quarter ended 30 Jun 2018 | 156 | 2(1.1%) | 40 | 8(26.3%) | -14 | 49(77.8%) | ⚠ |
| Quarter ended 31 Mar 2018 | 155 | — | 32 | — | -64 | — | ⚠ |